| [1] |
Hong JY,Nam JW,Seo EK,et al.Daphnane diterpene esters with anti-proliferative activities against human lung cancer cells from Daphne genkwa[J].Chem Pharm Bull,2010,58(2):234-237.
|
| [2] |
Song Y,Zhang S,Liu H,et al.Determination of genkwanin in rat plasma by liquid chromatography-tandem mass spectrometry:application to a bioavailability study[J].J Pharm Biomed Anal,2013,84(84C):129-134.
|
| [3] |
Li YN,Yin LH,Xu LN,et al.A simple and efficient protocol for large-scale preparation of three flavonoids from the flower of Daphne genkwa by combination of macroporous resin and counter-current chromatography[J].J Sep Sci,2010,33(14):2168-2175.
|
| [4] |
Chen Y,Guo J,Tang Y,et al.Pharmacokinetic profile and metabolite identification of yuanhuapine,a bioactive component in Daphne genkwa by ultra-high performance liquid chromatography coupled with tandem mass spectrometry[J].J Pharm Biomed Anal,2015,112:60-69.
|
| [5] |
Ying BP,Wang CS,Chou PN,et al.Studies on the active principles of the root of Yuan-Hua(Daphne Genkwa)[J].Acta Chimi Sin(化学学报),1978,35(1,2):103-108.
|
| [6] |
Zhan ZJ, Fan CQ, Ding J, et al. Novel diterpenoids with potent inhibitory activity against endothelium cell HMEC and cytotoxic activities from a well-known TCM plant Daphne genkwa[J].Bioorg Med Chem,2005,13(3):645-655.
|
| [7] |
Qiao Y,Zhao Y,Wu Q,et al.Full toxicity assessment of Genkwa Flos and the underlying mechanism in nematode Caenorhabditis elegans[J].PLoS ONE,2014,9(3):e91825.
|
| [8] |
Chen YY,Guo JM,Qian YF,et al.Toxicity of daphnane-type diterpenoids from Genkwa Flos and their pharmacokinetic profile in rat[J].Phytomedicine,2013,21(1):82-89.
|
| [9] |
Jiang Y,Gu L,Zhang R,et al.Evaluation of the indicative roles of seven potential biomarkers on hepato-nephrotoxicity induced by Genkwa Flos[J].J Ethnopharmacology,2014,158P A(3):317-324.
|
| [10] |
Ding L,Hong XH.The current situation and perspective of TCM aerosols[J].Chin J Integr Med(中国中西医结合杂志),2007,27(10):957-958.
|
| [11] |
Tang Y, Zhu JB, Gan L. Effect of HPMC capsule shell on the behaviour of dry powder inhalants[J].J China Pharm Univ(中国药科大学学报),2004,35(1):32-35.
|
| [12] |
Karhu M,Kuikka J,Kauppinen T,et al.Pulmonary deposition of lactose carriers used in inhalation powders[J].Int J Pharm,2000,196(1):95-103.
|
| [13] |
Kaialy W,Martin GP,Larhrib H,et al.The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers[J].Colloids Surf B Biointerfaces,2012,89(89):29-39.
|
| [14] |
Cao W,Chen Y,Zhang ZH.Application of lactose in dry powder inhaler[J].Chin J Mod Appl Pharm(中国现代应用药学),2012,29(7):591-596.
|
| [15] |
Council of Europe.European Pharmacopoeia(欧洲药典)[S].France:European Directorate for the Quality of Medicines,2013:309.
|
百度学术
下载:
